NORMITEN 100

국가: 이스라엘

언어: 영어

출처: Ministry of Health

지금 구매하세요

환자 정보 전단 환자 정보 전단 (PIL)
20-02-2022
제품 특성 요약 제품 특성 요약 (SPC)
01-11-2021
공공 평가 보고서 공공 평가 보고서 (PAR)
17-08-2016

유효 성분:

ATENOLOL

제공처:

ABIC LTD.

ATC 코드:

C07AB03

약제 형태:

TABLETS

구성:

ATENOLOL 100 MG

관리 경로:

PER OS

처방전 유형:

Required

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

치료 영역:

ATENOLOL

치료 징후:

For the treatment of angina pectoris, acute myocardial infarction, hypertension.

승인 날짜:

2020-04-30

환자 정보 전단

                                ربكأ ةيئاود ةعرج تلوانت اذإ
علب اذإ وأ ،ءاودلا نم ةطرفم ةيئاود
ةعرج تلوانت اذإ
بيبطلا ىلإ
ً
اروف هجوتلا بجي ،ءاودلا نم أطخلاب لفط
ةبلع
ً
ابحطصم ىفشتسملا يف ئراوطلا ةفرغ ىلإ وأ
.كعم ءاودلا
ءاودلا لوانت تيسن اذإ
لوانتف ،بولطملا تقولا يف ءاودلا اذه
لوانت تيسن اذإ
ً
ابيرقت
ناح اذإ ،نكل .كلذ كركذت ةظحل
ةيئاود
ةعرج
ةعرجلا تيوفتب مقف ةيلاتلا ةيئاودلا
ةعرجلا لوانت دعوم
ةفعاضم
ةيئاود
ةعرج
لوانت زوجي لا .ةيسنملا ةيئاودلا
.ةيسنملا ةيئاودلا ةعرجلا نع ضيوعتلل
.بيبطلا ةيصوت بسح جلاعلا ىلع ةبظاوملا
بجي
ةراشتسإ نودب ءاودلاب جلاعلا نع فقوتلا
زوجي لا
ىلع نسحت أرط ولو ىتح ،
ً
اقبسم يلديصلا وأ بيبطلا
.ةيحصلا كتلاح
ءاودلا لوانت نع تفقوت اذإ
.بيبطلا ريشتست نأ لبق ءاودلا اذه لوانت
نع فقوتت لا
.يجيردت لكشب جلاعلا نع فقوتلا متي
،ةنيعم تلااح يف
؟جلاعلا حاجن يف ةمهاسملا عيطتست فيك صيخشت بجي !ةمتعلا يف ةيودلأا لوانت
زوجي لا ةيئاودلا ةعرجلا نم دكأتلاو ءاودلا عباط تاراظنلا عض .ءاود اهيف لوانتت ةرم لك
يف
.كلذ رملأا مزل اذإ ةيبطلا ،ءاودلا لامعتسإ لوح ةيفاضإ ةلئسأ كيدل
ترفوت اذإ
.يلديصلا وأ بيبطلا رشتسإ
ةيبناجلا ضارعلأا )4
ً
اضارعأ ببسي دق نتيمرون لامعتسإ نإ
،ءاود لكب امك
ةمئاق نم
شهدنت
لا .نيلمعتسملا ضعب دنع ةيبناج
.اهنم
ً
ايأ
يناعت لاأ زئاجلا نم .ة
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                NORMITEN LC 09/2021 Notification
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Normiten® 25
Normiten® 50
Normiten® 100
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Normiten 25: Atenolol 25 mg.
Normiten 50: Atenolol 50 mg.
Normiten 100: Atenolol 100 mg.
Excipients with known effect
: This medicine contains less than 1 mmol sodium (23 mg) per
tablet, that is to say essentially ‘sodium-free’.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
Normiten 25: white to off white octagonal flat tablet, debossed "Abic"
on one side
and "25" on the other side, with breakline between "2" and "5". The
tablet can be
divided into equal halves.
Normiten 50: white to off white octagonal flat tablet, debossed "Abic"
on one side
and "50" on the other side, with breakline between "5" and "0". The
tablet can be
divided into equal halves.
Normiten 100: white to off white octagonal flat tablet, debossed
"ABIC" on one
side and "100" on the other side
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Normiten is indicated in the treatment of:
• Hypertension.
• Angina pectoris.
• Myocardial infarction.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The dose must always be adjusted to individual requirements of the
patients, with the lowest
possible starting dosage.
The following are guidelines:
Adults
NORMITEN LC 09/2021 Notification
_Hypertension _
Initially 25-50 mg once a day, the dosage being increased gradually to
100 mg a day after two
weeks, as needed and tolerated.
_Angina _
Initially 50 mg once a day, the dosage being increased gradually to
100 mg after 1 week, as
needed and tolerated.
_Myocardial infarction _
For patients who present some days after suffering an acute myocardial
infarction, an oral dose of
Normiten 100 mg daily is recommended for long-term prophylaxis of
myocardial infarction
Older population
Dosage requirements may be reduced, especially in patients with
impaired renal function.
Paediatric population
There is no paediatric experience with Ate
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 아랍어 20-02-2022
환자 정보 전단 환자 정보 전단 히브리어 20-02-2022

이 제품과 관련된 검색 알림

문서 기록보기